Drug Metabolism and Pharmacokinetics Research Laboratories, Takeda Pharmaceutical Company Ltd., 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, Japan.
Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company Ltd., 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, Japan.
J Pharm Sci. 2017 Sep;106(9):2787-2794. doi: 10.1016/j.xphs.2017.03.003. Epub 2017 Mar 16.
Although several mathematical models have been reported for the estimation of human plasma concentration profiles of drug substances after dermal application, the successful cases that can predict human pharmacokinetic profiles are limited. Therefore, the aim of this study is to investigate the prediction of human plasma concentrations after dermal application using in vitro permeation parameters obtained from excised human skin. The in vitro skin permeability of 7 marketed drug products was evaluated. The plasma concentration-time profiles of the drug substances in humans after their dermal application were simulated using compartment models and the clinical pharmacokinetic parameters. The transdermal process was simulated using the in vitro skin permeation rate and lag time assuming a zero-order absorption. These simulated plasma concentration profiles were compared with the clinical data. The result revealed that the steady-state plasma concentration of diclofenac and the maximum concentrations of nicotine, bisoprolol, rivastigmine, and lidocaine after topical application were within 2-fold of the clinical data. Furthermore, the simulated concentration profiles of bisoprolol, nicotine, and rivastigmine reproduced the decrease in absorption due to drug depletion from the formulation. In conclusion, this simple compartment model using in vitro human skin permeation parameters as zero-order absorption predicted the human plasma concentrations accurately.
尽管已经有几种数学模型被报道用于估计药物经皮给药后的人体血浆浓度曲线,但能够预测人体药代动力学曲线的成功案例有限。因此,本研究旨在通过从离体人皮肤上获得的体外渗透参数来研究经皮给药后预测人体血浆浓度的方法。评估了 7 种市售药物的体外皮肤渗透性。使用房室模型和临床药代动力学参数模拟了药物经皮给药后人体的血浆浓度-时间曲线。假设零级吸收,通过体外皮肤渗透速率和滞后时间模拟透皮过程。将这些模拟的血浆浓度曲线与临床数据进行比较。结果表明,双氯芬酸的稳态血浆浓度和尼古丁、比索洛尔、利伐斯的明和利多卡因的最大浓度经皮给药后与临床数据的比值在 2 倍以内。此外,比索洛尔、尼古丁和利伐斯的明的模拟浓度曲线再现了由于制剂中药物耗尽而导致的吸收减少。总之,该简单的房室模型使用体外人体皮肤渗透参数作为零级吸收,能够准确预测人体血浆浓度。